Breast Cancer
|
A Phase I Study of Infusion of HER-2/neu Specific T Cells in Patients with Advanced Stage HER-2/neu Expressing Cancers Who Have Received a HER-2/neu Vaccine
Scientific Description |
Clinical Description
|
A Phase II study of a HER-2/neu (HER2) intracellular domain (ICD) peptide-based vaccine administered to Stage IIIB and IV HER2 positive breast cancer patients receiving trastuzumab monotherapy
Scientific Description |
Clinical Description
|
A Phase I/II Study of Adoptive T Cell Therapy Following in vivo
Priming with a HER-2/neu (HER2) Intracellular Domain (ICD) Peptide-Based Vaccine in Patients with Advanced Stage HER2 Overexpressing (HER2+) Breast Cancer
Scientific Description |
Clinical Description
|
A Phase II Study of Topical Imiquimod and Weekly Abraxane for the Treatment of Breast Cancer Cutaneous Metastases
Scientific Description |
Clinical Description
|
|
